Profil
Wessam Sonbol is the founder of Delve Health LLC, where he currently holds the title of Chief Executive Officer & Director.
The company was founded in 2018.
Postes actifs de Wessam Sonbol
| Sociétés | Poste | Début |
|---|---|---|
Delve Health LLC
 Delve Health LLC Information Technology ServicesTechnology Services Delve Health LLC is a privately held company that specializes in digital healthcare and decentralized clinical trials. Delve Health is based in Golden Valley, MN, with remote offices in DC, Belize, and other locations. The company offers a customizable, end-to-end solution for each individual study, with a fully-configurable unified platform. The company's team is dedicated to improving virtual, hybrid, and traditional clinical studies with technology solutions for patients and clinical researchers. The company provides optimized randomization (IRT) and clinical trial supply management (RTSM) processes to automate study design, with a focus on patient compliance, retention, and overall experience. The company's mission is to help teams reduce clinical trial costs, increase patient retention, boost inclusivity, and improve patient outcomes. The company was founded by Wessam Sonbol and Tamer Swidan, with Wessam Sonbol serving as CEO since incorporation. | Fondateur | 01/01/2018 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Delve Health LLC
Delve Health LLC Information Technology ServicesTechnology Services Delve Health LLC is a privately held company that specializes in digital healthcare and decentralized clinical trials. Delve Health is based in Golden Valley, MN, with remote offices in DC, Belize, and other locations. The company offers a customizable, end-to-end solution for each individual study, with a fully-configurable unified platform. The company's team is dedicated to improving virtual, hybrid, and traditional clinical studies with technology solutions for patients and clinical researchers. The company provides optimized randomization (IRT) and clinical trial supply management (RTSM) processes to automate study design, with a focus on patient compliance, retention, and overall experience. The company's mission is to help teams reduce clinical trial costs, increase patient retention, boost inclusivity, and improve patient outcomes. The company was founded by Wessam Sonbol and Tamer Swidan, with Wessam Sonbol serving as CEO since incorporation. | Technology Services |
